ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Short Interest Update

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling 25,624 shares, a drop of 50.8% from the December 15th total of 52,121 shares. Currently, 1.0% of the shares of the company are short sold. Based on an average daily volume of 43,424 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily volume of 43,424 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.0% of the shares of the company are short sold.

Institutional Investors Weigh In On ALPS Medical Breakthroughs ETF

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp acquired a new stake in ALPS Medical Breakthroughs ETF in the 1st quarter valued at about $782,000. Moran Wealth Management LLC acquired a new position in shares of ALPS Medical Breakthroughs ETF during the 2nd quarter valued at about $300,000. Strategic Financial Services Inc. raised its position in shares of ALPS Medical Breakthroughs ETF by 97.8% in the 2nd quarter. Strategic Financial Services Inc. now owns 38,032 shares of the company’s stock worth $1,144,000 after buying an additional 18,807 shares during the period. Ally Invest Advisors Inc. acquired a new position in ALPS Medical Breakthroughs ETF during the second quarter valued at approximately $200,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of ALPS Medical Breakthroughs ETF in the second quarter worth $82,000.

ALPS Medical Breakthroughs ETF Stock Performance

Shares of ALPS Medical Breakthroughs ETF stock traded down $1.26 during trading on Thursday, reaching $51.22. The company’s stock had a trading volume of 21,823 shares, compared to its average volume of 54,362. ALPS Medical Breakthroughs ETF has a fifty-two week low of $22.33 and a fifty-two week high of $52.90. The company has a 50-day moving average price of $49.58 and a two-hundred day moving average price of $41.09.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.